The Bombay Sensex 30 has been one of the poorer performing indexes of 2015, with year-to-date returns in the region of -4.75%. The index is currently trading at 26,192.98, and the 52-week range is 24,833.54 on the low-end and 30,024.74 on the high end. It is interesting to note that the 1-year return is also negative at -1.98%. This cap-weighted index selects index members based on multiple factors including the following: floating-stock adjustment depth, liquidity, depth, and representation in the industry. The index had a base year of 100 in 1978/1979 and the free float methodology was adopted in 2003.

Sensex 30, 1-year Performance

The best performing companies comprising the Bombay 30 include the following: Axis Bank Ltd which is a private banking institution, Maruti Suzuki an automobiles/passenger cars manufacturer, HDFC Bank a private banking institution, Infosys an IT software enterprise, Sun Pharma a pharmaceuticals and drug manufacturing company, Lupin a pharmaceuticals and drug company, and Dr Reddy’s labs a pharmaceutical and drug manufacturing company. It is clear that the most successful companies which make up the Bombay Sensex 30 are largely in the pharmaceuticals and drug manufacturing sector. This has been one of India’s strengths for decades, as low-costs and lack of stringent regulations allows for the mass production of pharmaceutical products for worldwide distribution.

Strong Performers in Bombay Sensex 30

The aforementioned companies have proven themselves in terms of their performance over the past 365 days. Many companies in the Bombay Sensex 30 have racked up negative performance over the past 1 year. However the following are the most successful Bombay Sensex 30 companies over the past 365 days (in terms of improved performance in percentage terms):

·         Maruti Suzuki 1-year change of +47.48%

·         Lupin 1-year change of +36.58%